Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
US8367116B2 · kind B2 · utility
7Cited by
9References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2011 |
| Grant date | Feb 5, 2013 |
| Priority date | — |
| Expiry date | Mar 18, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for treating a subject who has suffered from a central nervous system disorder. More particularly, the invention provides sustained polymeric drug delivery systems having a polymer particle, a therapeutic agent, and a buoyancy agent for direct delivery of therapeutic agents into the central nervous system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.